TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK)

CUSIP: 874060205

Q3 2020 13F Holders as of 30 Sep 2020

Security type / class
Equity / SPONSORED ADS
Total 13F shares
107,411,892
Total 13F value
$1,906,842,183
Share change
-4,182,117
Put/Call ratio
122%
SEC-reported price per share
$17.84
Number of holders
296
Value change
-$74,858,671
Number of buys
121
Open additional details 1 more signal available
Number of sells
118

Security key

874060205

Report period

Q3 2020

Institutions

296

Top holders

10

TAK full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2020 Previous quarter: Q2 2020 TAKEDA PHARMACEUTICAL CO LTD SEC filings TAKEDA PHARMACEUTICAL CO LTD company facts TAKEDA PHARMACEUTICAL CO LTD 13D/G history

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
GLENVIEW CAPITAL MANAGEME...
Disclosed value leader
GLENVIEW CAPITAL MANAGEME...
Comparable rows
0/15
Latest evidence
30 Jun 2020
13F Highest disclosed value: $290,382,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

GLENVIEW CAPITAL MANAGEMENT, LLC has the largest disclosed position value at $290.38M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens GLENVIEW CAPITAL MANAGEMENT, LLC's linked filing trail.
Disclosed position value Top 5
GLENVIEW CAPITAL MANAGEMENT, LLC $290.38M
PAULSON & CO. INC. $205.96M
Adelphi Capital LLP $164.17M
RENAISSANCE TECHNOLOGIES LLC $100.55M
PRICE T ROWE ASSOCIATES INC /MD/ $98.53M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
GLENVIEW CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
class O/S missing
$290,382,000
16,195,310 shares
 — 30 Jun 2020
PAULSON & CO. INC.
13F
Company
13F
—
class O/S missing
$205,960,000
11,486,905 shares
 — 30 Jun 2020
Adelphi Capital LLP
13F
Company
13F
—
class O/S missing
$164,172,000
9,156,315 shares
 — 30 Jun 2020
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
class O/S missing
$100,546,000
5,607,700 shares
 — 30 Jun 2020
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
class O/S missing
$98,531,000
5,495,336 shares
 — 30 Jun 2020
VANGUARD GROUP INC
13F
Company
13F
—
class O/S missing
$81,368,000
4,538,071 shares
 — 30 Jun 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
296
Shares
107,411,892
Rows available
296
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders
291
Q3 2020 holders
296
Holder diff
5
Investor Q2 2020 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2020 value Q3 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .